Crohn's Disease and Colitis Trial, By Invitation NCT07171593 Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, By Invitation

NCT07171593
By Invitation Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with active Crohn's disease and were seen at the Sixth Affiliated Hospital of Sun Yat-sen University between July 2023 and December 2024
  • You are between 18 and 50 years old
  • You have also been diagnosed with sarcopenia (a condition where you have low muscle mass and strength)
  • You are willing and able to follow a liquid/formula-only diet taken by mouth as part of your treatment
  • You are willing to sign a consent form and follow all the steps involved in the study
  • Your Crohn's disease affects your colon or both your colon and small intestine, and has reached a certain level of severity based on a scoring system used by doctors (confirm with trial site)

Who may not be able to join:

  • You have short bowel syndrome (a condition where a large part of your small intestine is missing or not working)
  • You have a high-output fistula (an abnormal opening in your gut that leaks a large amount of fluid)
  • You are currently in a state of severe physical stress or shock
  • You have a complete blockage in your bowel, active bleeding in your gut, or a serious infection inside your abdomen
  • You have severe liver, kidney, or heart disease, or any form of cancer
  • You have a known allergy or medical reason not to take the nutritional supplements Ensure or HMB
  • You experience persistent severe vomiting or diarrhoea that cannot be controlled
  • You have an inherited condition affecting how your body processes sugars or proteins (confirm with trial site)
  • You have had bowel surgery related to Crohn's disease, or received a biologic medication in the past month, or taken immunosuppressant or antibiotic medicines for Crohn's disease in the past two weeks

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Registry
ClinicalTrials.gov
Start date
4 March 2024
Est. completion
22 May 2024

Where this trial is recruiting

🇨🇳 China

Primary endpoints

muscle strength improvement

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov